Literature DB >> 25832868

Paradoxical worsening of pemphigus vulgaris following rituximab therapy.

R J Feldman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25832868     DOI： 10.1111/bjd.13823

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  How to decrease systemic corticosteroids in pemphigus patients under rituximab.

Authors:  Fabrizio Martora; Vincenzo Picone; Gabriella Fabbrocini; Matteo Megna
Journal:  Health Sci Rep       Date:  2022-06-06

Review 2.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

3.  Aggressive course of pemphigus vulgaris following COVID-19 infection.

Authors:  Fariba Ghalamkarpour; Mohammad Reza Pourani
Journal:  Dermatol Ther       Date:  2020-11-08       Impact factor: 3.858

4.  Chromosome 2q33genetic polymorphisms in Tunisian endemic pemphigus foliaceus.

Authors:  Olfa Abida; Emna Bahloul; Mariem Ben Jmaa; Khadija Sellami; Ferjani Zouidi; Raouia Fakhfakh; Nadia Mahfoudh; Hamida Turki; Hatem Masmoudi
Journal:  Mol Genet Genomic Med       Date:  2020-09-01       Impact factor: 2.183
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.